• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞介导的针对人黑色素瘤和结肠直肠癌的细胞毒性中的单克隆抗体。

Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.

作者信息

Herlyn D, Herlyn M, Steplewski Z, Koprowski H

出版信息

Eur J Immunol. 1979 Aug;9(8):657-9. doi: 10.1002/eji.1830090817.

DOI:10.1002/eji.1830090817
PMID:499332
Abstract

Hybridoma-derived monoclonal anti-melanoma antibodies and anti-colorectal carcinoma antibodies were found to mediate in vitro antibody dependent cell-mediated cytotoxicity (ADCC) reactions against melanoma and colorectal carcinoma cells, respectively. The antigen(s) detected in ADCC on melanoma cells maintained for more than one hundred passages in tissue culture were also found on two recently established melanoma cell lines. These antigens were not detected on skin fibroblasts of the same patients from whom the melanomas were obtained. The ADCC reactivities of anti-melanoma and anti-colorectal carcinoma antibodies were found to be specific for melanoma cells and colorectal carcinoma cells, respectively.

摘要

发现杂交瘤衍生的抗黑色素瘤单克隆抗体和抗结肠直肠癌抗体分别介导针对黑色素瘤细胞和结肠直肠癌细胞的体外抗体依赖性细胞介导的细胞毒性(ADCC)反应。在组织培养中传代超过一百代的黑色素瘤细胞上通过ADCC检测到的抗原,在两个最近建立的黑色素瘤细胞系上也被发现。在获取黑色素瘤的同一患者的皮肤成纤维细胞上未检测到这些抗原。发现抗黑色素瘤和抗结肠直肠癌抗体的ADCC反应分别对黑色素瘤细胞和结肠直肠癌细胞具有特异性。

相似文献

1
Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.细胞介导的针对人黑色素瘤和结肠直肠癌的细胞毒性中的单克隆抗体。
Eur J Immunol. 1979 Aug;9(8):657-9. doi: 10.1002/eji.1830090817.
2
Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.单克隆抗体对裸鼠结直肠癌生长的抑制作用
Cancer Res. 1980 Mar;40(3):717-21.
3
Characterization of monoclonal antibodies to human melanoma-associated antigens.抗人黑色素瘤相关抗原单克隆抗体的特性鉴定
J Natl Cancer Inst. 1981 Mar;66(3):489-96.
4
Monoclonal antibodies to human tumor antigens.针对人类肿瘤抗原的单克隆抗体。
Transplant Proc. 1980 Sep;12(3):384-7.
5
Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.利用鼠单克隆抗体分析人抗体依赖性细胞毒性中的效应细胞。
J Immunol. 1987 May 15;138(10):3566-72.
6
Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.重组γ干扰素与鼠单克隆抗体CO17-1A用于晚期结直肠癌的II期试验中的抗体递送与效应细胞激活
Cancer Res. 1988 May 1;48(9):2568-73.
7
Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells.人结肠直肠癌和黑色素瘤细胞释放单克隆抗体定义的抗原。
Cancer Res. 1981 Jul;41(7):2723-7.
8
Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.针对17-1A抗原的非竞争性单克隆抗体组合增强对结肠癌的细胞毒性作用。
Cancer Res. 1988 Nov 15;48(22):6303-8.
9
Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.抗人结肠直肠癌相关抗原的鼠单克隆IgG3抗体:在抗体依赖性细胞毒性和补体介导的细胞溶解中均具有活性的抗体的产生及特性分析
Cancer Res. 1989 May 15;49(10):2766-72.
10
Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.具有人癌特异性的人IgG1亚类小鼠-人嵌合单克隆抗体的结合和功能特性
Hum Antibodies Hybridomas. 1990;1(2):66-76.

引用本文的文献

1
Nanotherapeutic strategies exploiting biological traits of cancer stem cells.利用癌症干细胞生物学特性的纳米治疗策略。
Bioact Mater. 2025 Apr 3;50:61-94. doi: 10.1016/j.bioactmat.2025.03.016. eCollection 2025 Aug.
2
Regulation of the Function and Expression of EpCAM.上皮细胞黏附分子(EpCAM)功能与表达的调控
Biomedicines. 2024 May 20;12(5):1129. doi: 10.3390/biomedicines12051129.
3
Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways.基于实体瘤肿瘤干细胞的启示:针对肿瘤促进因子和通路的治疗进展。
Int J Mol Sci. 2024 Apr 7;25(7):4102. doi: 10.3390/ijms25074102.
4
Recent advances in CAR-T cells therapy for colorectal cancer.嵌合抗原受体 T 细胞疗法治疗结直肠癌的最新进展。
Front Immunol. 2022 Sep 27;13:904137. doi: 10.3389/fimmu.2022.904137. eCollection 2022.
5
NK Cell-Based Immunotherapy in Colorectal Cancer.基于自然杀伤细胞的结直肠癌免疫疗法。
Vaccines (Basel). 2022 Jun 28;10(7):1033. doi: 10.3390/vaccines10071033.
6
Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy.靶向肿瘤免疫微环境中的Wnt信号通路以增强EpCAM嵌合抗原受体T细胞疗法。
Front Pharmacol. 2021 Nov 1;12:724306. doi: 10.3389/fphar.2021.724306. eCollection 2021.
7
Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.上皮-间充质转化过程中 EpCAM 的动态调控的功能意义。
Biomolecules. 2021 Jun 29;11(7):956. doi: 10.3390/biom11070956.
8
Current View on EpCAM Structural Biology.当前对 EpCAM 结构生物学的认识。
Cells. 2020 May 31;9(6):1361. doi: 10.3390/cells9061361.
9
EpCAM homo-oligomerization is not the basis for its role in cell-cell adhesion.EpCAM 同源寡聚化不是其在细胞间黏附中作用的基础。
Sci Rep. 2018 Sep 5;8(1):13269. doi: 10.1038/s41598-018-31482-7.
10
EpCAM Intracellular Domain Promotes Porcine Cell Reprogramming by Upregulation of Pluripotent Gene Expression via Beta-catenin Signaling.EpCAM 细胞内结构域通过β-连环蛋白信号通路上调多能基因表达促进猪细胞重编程。
Sci Rep. 2017 Apr 10;7:46315. doi: 10.1038/srep46315.